Genetic alterations associated with the evolution and progression of astrocytic brain tumours

Virchows Archiv

Volumn 427, Issue 2, 1995, Pages 113-118

  Ohgaki, H ^a   Kleihues, P ^a,b   Schauble B ^b   zur Hausen, A ^b   von Ammon, K ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Astrocytoma; Oncogene; Tumour suppressor gene

Indexed keywords

CARCINOGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ASTROCYTOMA; CANCER CLASSIFICATION; CELL TRANSFORMATION; CHROMOSOME 10; CHROMOSOME 17P; CHROMOSOME 19Q; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; GLIOBLASTOMA; HETEROZYGOSITY; HUMAN; NERVOUS SYSTEM TUMOR; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; DISEASE PROGRESSION; GENES, P53; GLIOBLASTOMA; HUMAN; MUTATION;

EID: 0028882666     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/BF00196514     Document Type: Review

References (44)

1. Cytogenetic and molecular genetics of malignant gliomas and medulloblastoma
2. Gene amplification in malignant human gliomas: clinical and histopathologic aspects
3. Grading of astrocytomas. A simple and reproducible method
4. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
5. p53 Mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency
6. p53 Mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
7. Mutation rate of the CDKN2 gene in malignant gliomas
8. CDK4 Amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines
9. p53 Mutations in human cancers
10. Database of p53 gene somatic mutations in human tumors and cell lines
11. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing
12. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis
13. Molecular genetic characterization of CNS tumor oncogenesis
14. Clonal genomic alterations in glioma malignancy stages
15. Deletion of p16 and p15 in brain tumors
16. The new classification of brain tumors
17. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors
18. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas
19. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis
20. The p53 gene and protein in human brain tumors
21. Comparative study of p53 gene and protein alterations in human astrocytomas
22. Detection of p53 gene mutations in human brain tumours by single strand conformation polymorphism analysis of polymerase chain reaction products
23. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
24. Mutations of the tumor suppressor gene p53 in neoplasms of human nervous system
25. Alterations of the TP53 gene in human gliomas
26. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
27. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2
28. Expression of the tumor suppressor gene DCC in human gliomas
29. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of gliomas
30. Clonal expansion of p53 mutant cells is associated with brain tumor progression
31. Brain tumours and occupational risk factors. A review
32. Multiple sequential molecular abnormalities in the evolution of human gliomas
33. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p
34. p53 Mutations correlate with 17p allelic loss in grade II and grade III astrocytoma
35. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme
36. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas
37. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma
38. Subsets of glioblastoma multiforme defined by molecular genetic analysis
39. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas
40. Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma
41. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification